HomeAboutServicesBlogNewsContact Us
Our Services

End-to-End Pharmaceutical Consultancy

Batch release, dossier diligence, PV audits, gap analysis, and market access strategy — practical support from someone who stays until it's done.

What We Offer
Tailored Solutions Across the Pharmaceutical Lifecycle

Most of what I do falls into one of three areas: keeping your licences in good shape, making sure your safety reporting actually works, and getting your regulatory submissions through without unnecessary back-and-forth.

In practice that means QP and RP batch release, GMP/GDP gap analysis, dossier diligence before you file, PV system audits that go beyond ticking boxes, and market access strategy that accounts for how regulators actually think — not just how the guidance reads on paper.

I work with generic pharmaceutical companies, virtual MAHs, contract manufacturers, and importers. Most clients come to me when something needs fixing properly, or when they're building a compliance function from scratch and need someone who's done it before.

Why Work With Me

I'm on Your Licence, Not in an Office

Named QP, RP, and RPi on live licences — I carry the personal liability, so I take it seriously.

Built for Inspection Scrutiny

Everything I deliver is written with one question in mind: would this hold up if an MHRA inspector asked about it tomorrow?

I Don't Hand Over a Report and Leave

Gap analysis, implementation, troubleshooting — I stay through the messy middle until the system actually works.

01

Licensing & GxP Compliance

QP, RP, and RPi services for marketing authorisation holders, wholesale distributors, and importers — plus GMP/GDP auditing and inspection readiness.

02

Pharmacovigilance

End-to-end safety and vigilance support — from PV system establishment and PSMF maintenance through to expedited reporting and MHRA Gateway submissions.

03

Regulatory Affairs

Strategic regulatory support from initial MA applications through post-approval lifecycle management — variations, renewals, dossier diligence, deficiency responses, and market access strategy.

Licensing & Compliance

QP Batch Certification & Release

Qualified Person services for the certification and batch release of medicinal products in compliance with EU GMP Annex 16 and UK requirements. Every batch is personally reviewed — CoAs, manufacturing records, deviations, and transport data.

QP certification of finished products
Batch documentation review
QP oversight and governance
Import batch testing coordination
QP declarations and submissions
Annex 16 compliance

How I Actually Work

I don't rubber-stamp batch records. Every QP certification starts with me personally going through the manufacturing data, the CoAs, the deviations log, and any open investigations. If something doesn't add up, I pick up the phone.

Third-country imports: I coordinate UK retesting, review the CoA against the MA spec, check transit temperature data, and only then certify. No shortcuts.
Licensing & Compliance

RP & RPi Services

Named Responsible Person and Responsible Person for Import services for wholesale distribution and importation under MHRA licensing. Active oversight of GDP compliance, cold chain integrity, and supply chain operations.

Named RP for WDA(H) licences
RPi for MIA(IMP) and import
GDP compliance oversight
Supply chain integrity
Temperature mapping & cold chain
FMD compliance

What Being a Named RP Actually Means

It means I'm personally responsible if something goes wrong with your distribution operation. So I make sure it doesn't — supplier qualification, complaint follow-ups, recall readiness, GDP compliance checks. Not once a year. Ongoing.

Licence types I support: WDA(H), MIA, MIA(IMP), MS (Specials), and Marketing Authorisations.
Licensing & Compliance

GMP/GDP Consultancy & Auditing

Expert consultancy and auditing to ensure operations meet current Good Manufacturing Practice and Good Distribution Practice standards. Gap analysis, supplier auditing, and quality system improvement.

GMP/GDP gap analysis
Supplier & third-party auditing
Quality system improvement
CAPA & deviation management
SOP development & review
Quality Risk Management (ICH Q9)

How I Audit

I don't use generic checklists. Audits are built around the actual EU GMP chapters, relevant annexes, and EMA reflection papers that apply to your operation. Findings come with a risk rating and a clear path to close them out.

I've audited: Manufacturing sites, contract labs, API suppliers, packaging lines, and warehouse operations — across multiple countries and product types.
Licensing & Compliance

Regulatory Compliance & Inspection Readiness

Prepare for MHRA inspections and maintain ongoing compliance with evolving pharmaceutical regulations. From mock inspections through remediation and post-inspection CAPA management.

MHRA inspection readiness
Mock inspections & remediation
Regulatory submissions support
Change control & variation
Post-inspection CAPA
Licence application & maintenance

Been There, Done That

I've been through MHRA inspections on both sides — as the named responsible person being inspected, and as the consultant helping someone else get ready. That experience makes a difference when it comes to knowing where inspectors look and what trips people up.

What I cover: Document review, staff interview prep, front room and back room coordination, and if it comes to it, drafting your post-inspection response.
Safety & Vigilance

Pharmacovigilance

End-to-end pharmacovigilance support ensuring compliance with UK GVP, HMR 2012, and international safety reporting obligations. From PV system establishment for new MAHs through to ongoing signal detection and regulatory submissions.

PV system setup & PSMF maintenance
QPPV & local PV contact services
Expedited & periodic safety reporting
Signal detection & risk management
PV auditing & inspection readiness
Safety database (Argus) oversight
MHRA Gateway submissions
DHPC & urgent safety restrictions

UK-Specific, Not a Generic EU Template

A lot of PV outsourcing is built around EU frameworks and then loosely adapted for the UK. I work the other way around — HMR 2012, MHRA UK GVP modules, and the MHRA Gateway are the starting point. The system is designed for the regulator who'll actually inspect it.

For virtual MAHs: I've built PV systems from scratch — RSI maintenance, aggregate report scheduling, Argus database demonstration readiness, the lot. Not templates. Actual working systems.
Regulatory Affairs

Regulatory Affairs

Strategic regulatory affairs support across the product lifecycle — dossier diligence before you submit, MA applications, post-approval variations, and market access strategy that balances regulatory requirements with commercial reality.

UK & EU MA applications
Dossier diligence & CTD review
Type IA, IB & Type II variations
Market access strategy
Regulatory strategy & pathway advice
Renewals & sunset clause management
Artwork & labelling compliance
Deficiency response management
Parallel import & licensing support

Getting Submissions Right First Time

The difference between a variation that sails through and one that gets a deficiency letter usually comes down to how well the justification is written. I handle everything from straightforward Type IAs through to complex Type IIs with stability data, spec changes, and cross-referencing — written to close the question, not open new ones.

Real example: Six drafts of a science-based justification for widening a release assay specification — built on pharmacopoeial alignment, measurement uncertainty data, and seven years of stability results. It went through.
Key Figures

6

Core Service
Disciplines

3

Active QP, RP & RPi
Designations Held

5

Licence Types
Supported

4

Regulatory
Frameworks

I've sat in enough inspection back rooms and reviewed enough failed dossiers to know that what most companies need isn't more advice — it's someone who'll actually roll up their sleeves and fix things.
Satish Davuluri — Founder & Principal Consultant, T&S Pharma Ltd

Got a Regulatory Problem That Needs Fixing?

Tell me what you're dealing with. If I can help, I'll tell you how. If I can't, I'll say so.

Get in Touch →